Brief: IGC Receives No Objection Letter From Health Canada
04/01/2023 13:10
Jan 4 (Reuters) - India Globalization Capital Inc
IGC.A :
* INDIA GLOBALIZATION CAPITAL INC - RECEIVES NO OBJECTION
LETTER
FROM HEALTH CANADA ON ITS PHASE 2 TRIAL OF IGC-AD1
Source text for Eikon: ID:nGNX4z4Tc4
Further company coverage: IGC.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGC Pharma
See all newsFocus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Cannabis stocks climb after Trump signs order to ease curbs on marijuana (updated)
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Brief: IGC Pharma's Unit Enters Sale Of Assets Agreement For $2.7 Million - SEC Filing
Brief: IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment